Jessen M, Bylander A
Dept. of O.R.L., Malmö General Hospital, University of Lund, Sweden.
Rhinology. 1990 Jun;28(2):77-81.
The effect of ipratropium and beclomethasone administered as nasal aerosols was compared in a double-blind, double-dummy, randomized, cross-over designed study. Twenty-four patients with non-allergic, watery hypersecretion participated in the trial. According to the patients' daily registration of nasal symptoms, no significant difference could be found between the two drugs. It was not possible to characterize patients who would benefit from treatment with either ipratropium or beclomethasone.
在一项双盲、双模拟、随机、交叉设计的研究中，比较了异丙托溴铵和倍氯米松鼻喷雾剂的效果。24例非过敏性水样分泌过多的患者参与了该试验。根据患者对鼻部症状的每日记录，两种药物之间未发现显著差异。无法确定哪些患者会从使用异丙托溴铵或倍氯米松治疗中获益。
